Suppression of human glioma growth by adenovirus-mediated Rb gene transfer

Neurology

Volumn 50, Issue 5, 1998, Pages 1307-1315

  Fueyo, Juan ^a   Gomez Manzano, C ^a   Yung, W K A ^a   Liu, T J ^a   Alemany, R ^a   Bruner, J M ^a   Chintala, S K ^a   Rao, J S ^a   Levin, V A ^a   Kyritsis, A P ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOBLASTOMA PROTEIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE TRANSFER; GENETIC TRANSDUCTION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; XENOGRAFT;

EID: 0031813862     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.5.1307     Document Type: Article

References (40)

1. Pardee AB. G1 events and regulation of cell proliferation. Science 1989;246:603-608.
2. Hartwell L, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821-1828.
3. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-330.
4. Goodrich DW, Wang NP, Qian Y-W, Lee Y-HP, Lee W-H. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 1991;67:293-302.
5. Weinberg RA. Tumor suppressor genes. Science 1992;254: 1138-1146.
6. Harbour WJ, Lai S-L, Wang-Peng J, Gazdar AF, Minna JD, Kaye FJ. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988;241: 353-357.
7. Xu H-J, Hu S-X, Cagle PT, Moore GE, Benedict WF. Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res 1991;51:2735-2739.
8. Bookstein R, Rio P, Madreperla SA, et al. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 1990;87:7762-7766.
9. Cance WG, Brennan MF, Dudas ME, Huang C-M, Cordon-Cardo CN. Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 1990;323:1457-1462.
10. Gennett IN, Cavanee WK. Molecular genetics in the pathology and diagnosis of retinoblastoma. Brain Pathol 1990;1:25-32.
11. Logothetis CJ, Xu H-J, Ro JY, et al. Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 1992;84: 1256-1261.
12. Trudel M, Mulligan L, Cavanee W, Margolese R, Cote J, Gariepy G. Retinoblastoma and p53 gene product expression in breast carcinoma. Hum Pathol 1992;23:1388-1394.
13. Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 1993;85:1121-1128.
14. Anker L, Hamel W, Laas R, Wesphal M. Immunodetection of tumor suppressor gene products in primary brain tumors and glioma cell lines. Clin Neuropathol 1991;10:10. Abstract.
15. Venter DJ, Bevan KL, Ludwig RL, et al. Retinoblastoma gene deletions in human glioblastomas. Oncogene 1991;5:445-448.
16. Godbout R, Miyakoshi J, Dobler KD, et al. Lack of expression of tumor-suppressor genes in human malignant glioma cell lines. Oncogene 1992;7:1879-1884.
17. Hamel W, Westphal M, Shepard HM. Loss in expression of the retinoblastoma gene product in human gliomas is associated with advanced disease. J Neurooncol 1993;16:159-165.
18. Henson JW, Schnitker BL, Correa KM, et al. The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 1994;36:714-721.
19. Hirvonen HE, Salonen R, Sandberg MM, et al. Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines. Br J Cancer 1994;69:16-25.
20. Fueyo J, Gomez-Manzano C, Bruner JM, et al. Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas. Oncogene 1996;13:1615-1619.
21. Ueki K, Ono Y, Henson JW, Efird JT, Von Deimling A, Louis DN. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 1996; 56:150-153.
22. Maxwell M, Galadopoulos T, Antoniades HN. Cell-cycle regulator cyclin D1 mRNA and protein overexpression occurs in primary malignant gliomas. Int J Oncol 1996;9:493-497.
23. He J, Allen JR, Collins VP, et al. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res 1994;54:5804-5807.
24. Costello JF, Plass C, Arap W, et al. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res 1997:57: 1250-1254.
25. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond) 1993;366:704-707.
26. Zhang W-W, Fang X, Branch CD, Mazur W, French BA, Roth JA. Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. Biotechniques 1993;15:868-872.
27. Hu G, Liu W, Hanania EG, Fu S, Wang T, Deisseroth AB. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Cancer Gene Ther1995;2:19-32.
28. Mcgrory WJ, Bautista DS, Graham FL. A simple technique for the rescue of early region I mutations into infectious human adenovirus type V. Virology 1988;163:614-617.
29. Lochmuller H, Jani A, Presott S, et al. Emergence of early region 1-containing replication-competent adenovirus in stocks in 293 cells. Hum Gene Ther 1994;5:1485-1491.
30. Steck PA, Gallick GE, Maxwell SA, et al. Expression of epidermal growth factor receptor and associated glycoprotein on cultured human brain tumor cells. J Cell Biochem 1986;32:1-10.
31. Fueyo J, Gomez-Manzano C, Yung WKA, et al. Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Oncogene 1996;12:103-110.
32. Attia MA, Weiss DW. Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain a mice infected with mammary tumor virus. Cancer Res 1966;26:1787-1800.
33. INK4 in human cancer. Proc Natl Acad Sci USA 1994;91:11045-11049.
34. Huang J-JS, Yee J-K, Shew J-Y, et al. Suppression of the neoplastic phenotype by replacement of the Rb gene in human cancer cells. Science 1988;242:1563-1566.
35. Gomez-Manzano C, Fueyo J, Kyritsis AP, et al. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res 1996;56:694-699.
36. Muller H, Lukas J, Schneider A, et al. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 1994;91:2945-2949.
37. INK4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 1995;92:6289-6293.
38. Arap W, Nishikawa IR, Furnari FB, Cavanee WK, Huang H-JS. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res 1995;55:1351-1354.
39. Le Gal La Salle G, Robert JJ, Bernard S, Ridoux V, Stratford-Perricaudet LD, Perricaudet M. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 1993;259: 988-990.
40. Chen S-H, Shine HD, Goodman JC, Grossman RG, Woo SLC. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 1994;91:3054-3057.